1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > eClinical Solutions Market by Product, Delivery Mode, Clinical Trial Phases, End User - Global Forecast to 2020

The global eClinical solutions market is estimated to grow at a high CAGR of 12.1% from 2015 to 2020. Although developed regions (such as North America and Europe) held large shares in the eClinical solutions market in 2015, the Asia-Pacific region is poised to grow at the highest CAGR of 16.1% in the next five years. Factors such as the increasing outsourcing of clinical trial studies by the large pharma and biopharma companies in Asia-Pacific countries, presence of large patient population, and low operating cost in conducting clinical trials are propelling the growth of the eClinical solutions market in this region.

The growth of the global eClinical solutions market is driven by factors such as rising adoption of software solutions during clinical trials, increasing R&D expenditure by pharmaceutical companies, growing government grants to support clinical research, and rising customer base. In addition, increasing clinical research in emerging Asian countries, shift of clinical trials and resources from AMCs to CROs, and developments of cost effective modules are offering new growth opportunities for the eClinical solutions vendors. Nonetheless, the high implementation cost, dearth of skilled research professionals, and lack of awareness of clinical data sciences software in research community are the key reasons hampering the growth of the eClinical solutions market. Besides, low software adoption rate in several geographic such as Middle East and Africa, and software reliability and patient privacy issues are also restricting the growth of the eClinical solutions market.

In this report, the eClinical solutions market has been segmented on the basis of product (covering electronic data capture (EDC) and clinical data management systems (CDMS), clinical trial management systems (CTMS), clinical analytics platform, randomization & trial supply management systems (RTMS), clinical data integration platforms, electronic clinical outcome assessment (eCOA), safety solutions, electronic trail master files (eTMF), and others (regulatory information management solutions, coding systems, and core laboratory integration solutions); delivery mode (including web-hosted (On-demand), licensed enterprise (On-premise), cloud-based (SaaS); clinical trial phase (phase I, phase II, phase III, and phase IV); end user (pharmaceutical and biopharmaceutical companies, contract research organizations, consulting service companies, medical device manufacturers, hospitals, and academic research institutions); and region (North America, Europe, Asia-Pacific, and the Rest of the World). The EDC and CDMS segment is estimated to account for the largest share of the global eClinical solutions market in 2015. However, the eCOA segment is expected to grow at the highest CAGR during the forecast period. Increasing demand for eDiaries in clinical studies to collect patient self-reports by major pharmaceutical companies and rising adoption of mobile and digital technologies are driving the growth of this market segment.

Geographically, North America is estimated to command the largest share of 59.6% of the global eClinical solutions market in 2015, followed by Europe. The large market share of the North American region is attributed to the significantly large number of ongoing clinical trials in this region. A number of factors such as the increasing government grants to support clinical trials, continuous product development and new product launches by eClinical solution vendors, growth in the number of partnerships for new drug development, and high prevalence of lifestyle diseases with increasing aging population are further stimulating the demand for eClinical solutions in North America. However, strict and lengthy government requirements and high cost of conducting clinical trials in the North American region are negatively affecting the growth of the eClinical solutions market in this region.

The eClinical solutions market is highly competitive, with a large number of global and local providers of eClinical solutions. Oracle Corporation (U.S.) Medidata Solutions, Inc. (U.S.), and PAREXEL International Corporation (U.S.) were the top three players in the eClinical solutions market in 2014. These companies together accounted for 44.9% of the global market. Partnerships, agreements, and collaborations; product launches and product enhancements; product deployments; mergers and acquisitions; and geographic expansions are the major strategies adopted by most of the market players to achieve growth in the eClinical solutions market.

Reasons to Buy the Report:

From an insight perspective, this research report focuses on various levels of analysis —market share analysis of the top players and company profiles, which together comprise and discuss basic views on the competitive landscape; emerging and high-growth segments of the eClinical solutions market; and high-growth regions and their respective drivers, restraints, challenges, and opportunities.

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms in garnering a greater market share. Firms purchasing the report could use any one or combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

- Market Penetration: Comprehensive information on eClinical solutions offered by the top 10 players in the eClinical solutions market. The report analyzes the eClinical solutions market by product, delivery mode, clinical trial phase, and end users across four geographies

- Product Development/Innovation: Detailed insights on current technologies, research and development activities, and new product launches in the eClinical solutions market

- Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various eClinical solutions across four geographies (North America, Europe, Asia-Pacific, and Rest of the World)

- Competitive Assessment: Assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the eClinical solutions market

Table Of Contents

eClinical Solutions Market by Product, Delivery Mode, Clinical Trial Phases, End User - Global Forecast to 2020
TABLE OF CONTENTS

1 INTRODUCTION 16
1.1 OBJECTIVES OF THE STUDY 16
1.2 MARKET DEFINITION 16
1.3 MARKET SCOPE 16
1.3.1 MARKETS COVERED 17
1.3.2 YEARS CONSIDERED FOR THE STUDY 18
1.4 CURRENCY 18
1.5 LIMITATIONS 18
1.6 STAKEHOLDERS 18
2 RESEARCH METHODOLOGY 19
2.1 RESEARCH DATA 19
2.1.1 SECONDARY DATA 20
2.1.1.1 Key data from secondary sources 20
2.1.2 PRIMARY DATA 21
2.1.2.1 Breakdown of primaries 21
2.1.2.2 Key data from primary sources 22
2.1.2.3 Key industry insights 23
2.2 MARKET SIZE ESTIMATION 23
2.2.1.1 Bottom-up approach 25
2.2.1.2 Top-down approach 26
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 27
2.4 RESEARCH ASSUMPTIONS 28
3 EXECUTIVE SUMMARY 29
3.1 INTRODUCTION 29
3.2 CURRENT SCENARIO 30
3.3 FUTURE OUTLOOK 31
3.4 CONCLUSION 34
4 PREMIUM INSIGHTS 35
4.1 eCLINICAL SOLUTIONS MARKET OVERVIEW 35
4.2 eCLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION) 36
4.3 GEOGRAPHIC ANALYSIS: eCLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2015 37
4.4 eCLINICAL SOLUTIONS MARKET SHARE, BY CLINICAL TRIAL PHASE, 2015 VS. 2020 38
4.5 eCLINICAL SOLUTIONS MARKET, BY END USER AND REGION, 2015 38

5 MARKET OVERVIEW 39
5.1 INTRODUCTION 39
5.2 MARKET SEGMENTATION 39
5.3 MARKET DYNAMICS 40
5.3.1 DRIVERS 41
5.3.1.1 Growing adoption of software solutions during clinical trials 41
5.3.1.2 Government grants to support clinical trials 41
5.3.1.3 Need for improved data standardization 42
5.3.1.4 Increasing research and development expenditure by pharmaceutical companies 42
5.3.1.5 Growing customer base 42
5.3.2 RESTRAINTS 43
5.3.2.1 High implementation costs 43
5.3.2.2 Dearth of skilled research professionals 43
5.3.2.3 Lack of awareness 43
5.3.3 OPPORTUNITIES 44
5.3.3.1 Increasing clinical research activities in emerging Asian countries 44
5.3.3.2 Increasing outsourcing of clinical trials to CROs 44
5.3.3.3 Development of cost-effective modules 44
5.3.3.4 Rising number of clinical trials 44
5.3.4 CHALLENGES 45
5.3.4.1 Low adoption 45
5.3.4.2 Software reliability 45
5.3.4.3 Patient privacy 45
6 eCLINICAL SOLUTIONS MARKET, BY PRODUCT 46
6.1 INTRODUCTION 47
6.2 ELECTRONIC DATA CAPTURE (EDC) AND CLINICAL DATA MANAGEMENT SYSTEMS (CDMS) 49
6.3 CLINICAL TRIAL MANAGEMENT SYSTEMS (CTMS) 51
6.4 CLINICAL ANALYTICS PLATFORMS 53
6.5 RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) 55
6.6 CLINICAL DATA INTEGRATION PLATFORMS 57
6.7 ELECTRONIC CLINICAL OUTCOME ASSESSMENT (eCOA) 59
6.8 SAFETY SOLUTIONS 60
6.9 ELECTRONIC TRIAL MASTER FILE (eTMF) 61
6.10 OTHER ECLINICAL SOLUTIONS 62

7 eCLINICAL SOLUTIONS MARKET, BY DELIVERY MODE 64
7.1 INTRODUCTION 65
7.2 WEB-HOSTED (ON-DEMAND) 66
7.3 LICENSED ENTERPRISE (ON-PREMISE) 68
7.4 CLOUD-BASED (SAAS) 69
8 eCLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE 70
8.1 INTRODUCTION 71
8.2 PHASE I 72
8.3 PHASE II 74
8.4 PHASE III 76
8.5 PHASE IV 78
9 eCLINICAL SOLUTIONS MARKET, BY END USER 80
9.1 INTRODUCTION 81
9.2 PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES 82
9.3 CONTRACT RESEARCH ORGANIZATIONS 84
9.4 CONSULTING SERVICE COMPANIES 86
9.5 MEDICAL DEVICE MANUFACTURERS 87
9.6 HOSPITALS 88
9.7 ACADEMIC RESEARCH INSTITUTES 89
10 eCLINICAL SOLUTIONS MARKET, BY REGION 90
10.1 INTRODUCTION 91
10.2 NORTH AMERICA 92
10.2.1 U.S. 95
10.2.2 CANADA 97
10.3 EUROPE 99
10.4 ASIA-PACIFIC 105
10.5 REST OF THE WORLD 109
11 COMPETITIVE LANDSCAPE 112
11.1 OVERVIEW 112
11.2 MARKET SHARE ANALYSIS 112
11.3 COMPETITIVE SITUATION AND TRENDS 114
11.3.1 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS 115
11.3.2 NEW PRODUCT LAUNCHES AND PRODUCT ENHANCEMENTS 116
11.3.3 PRODUCT DEPLOYMENT 117
11.3.4 MERGERS AND ACQUISITIONS 118
11.3.5 EXPANSION 119
11.3.6 OTHER DEVELOPMENTS 120
12 COMPANY PROFILES 121
(Overview, Financials, Products and Services, Strategy, and Developments)*
12.1 INTRODUCTION 121
12.2 ORACLE CORPORATION 122
12.3 MEDIDATA SOLUTIONS, INC. 128
12.4 PAREXEL INTERNATIONAL CORPORATION 132
12.5 BIOCLINICA, INC. (A SUBSIDIARY OF JLL PARTNERS) 136
12.6 DATATRAK INTERNATIONAL, INC. 139
12.7 CRF HEALTH 143
12.8 ERT 145
12.9 ECLINICAL SOLUTIONS, INC. 147
12.10 MERGE HEALTHCARE INCORPORATED 148
12.11 OMNICOMM SYSTEMS, INC. 150
*Details on Financials, Product and Services, Strategy, and Developments might not be captured in case of unlisted companies.
13 APPENDIX 154
13.1 DISCUSSION GUIDE* 154
13.2 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 158
13.3 AVAILABLE CUSTOMIZATIONS 159
13.4 RELATED REPORTS 160


LIST OF TABLES

TABLE 1 U.S.: LIST OF SOME LIFE SCIENCE STARTUPS LAUNCHED BETWEEN 2011 and 2014 43
TABLE 2 GLOBAL eCLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT,
2013-2020 (USD MILLION) 48
TABLE 3 GLOBAL ELECTRONIC DATA CAPTURE (EDC) AND CLINICAL DATA MANAGEMENT SYSTEMS (CDMS) MARKET SIZE, BY REGION, 2013-2020 (USD MILLION) 50
TABLE 4 NORTH AMERICA: ELECTRONIC DATA CAPTURE (EDC) AND CLINICAL DATA MANAGEMENT SYSTEMS (CDMS) MARKET SIZE, BY COUNTRY,
2013-2020 (USD MILLION) 50
TABLE 5 GLOBAL CLINICAL TRIAL MANAGEMENT SYSTEMS (CTMS) MARKET SIZE,
BY REGION, 2013-2020 (USD MILLION) 52
TABLE 6 NORTH AMERICA: CLINICAL TRIAL MANAGEMENT SYSTEMS (CTMS) MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION) 53
TABLE 7 GLOBAL CLINICAL ANALYTICS PLATFORMS MARKET SIZE, BY REGION,
2013-2020 (USD MILLION) 54
TABLE 8 NORTH AMERICA: CLINICAL ANALYTICS PLATFORMS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION) 55
TABLE 9 GLOBAL RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET SIZE, BY REGION, 2013-2020 (USD MILLION) 56
TABLE 10 NORTH AMERICA: RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION) 57
TABLE 11 GLOBAL CLINICAL DATA INTEGRATION PLATFORMS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION) 58
TABLE 12 NORTH AMERICA: CLINICAL DATA INTEGRATION PLATFORMS MARKET SIZE,
BY COUNTRY, 2013-2020 (USD MILLION) 58
TABLE 13 GLOBAL ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET SIZE,
BY REGION, 2013-2020 (USD MILLION) 59
TABLE 14 NORTH AMERICA: ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION) 60
TABLE 15 GLOBAL SAFETY SOLUTIONS MARKET SIZE, BY REGION,
2013-2020 (USD MILLION) 60
TABLE 16 NORTH AMERICA: SAFETY SOLUTIONS MARKET SIZE, BY COUNTRY,
2013-2020 (USD MILLION) 61
TABLE 17 GLOBAL ELECTRONIC TRIAL MASTER FILE MARKET SIZE, BY REGION,
2013-2020 (USD MILLION) 61
TABLE 18 NORTH AMERICA: ELECTRONIC TRIAL MASTER FILE (ETMF) MARKET SIZE,
BY COUNTRY, 2013-2020 (USD MILLION) 62
TABLE 19 GLOBAL OTHER eCLINICAL SOLUTIONS MARKET SIZE, BY REGION,
2013-2020 (USD MILLION) 62
TABLE 20 NORTH AMERICA: OTHER eCLINICAL SOLUTIONS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION) 63
TABLE 21 GLOBAL eCLINICAL SOLUTIONS MARKET SIZE, BY MODE OF DELIVERY,
2013-2020 (USD MILLION) 66
TABLE 22 WEB-HOSTED (ON-DEMAND) eCLINICAL SOLUTIONS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION) 67
TABLE 23 LICENSED ENTERPRISE (ON-PREMISE) eCLINICAL SOLUTIONS MARKET SIZE,
BY REGION, 2013-2020 (USD MILLION) 68
TABLE 24 CLOUD-BASED (SAAS) eCLINICAL SOLUTIONS MARKET SIZE, BY REGION,
2013-2020 (USD MILLION) 69
TABLE 25 GLOBAL eCLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE,
2013-2020 (USD MILLION) 71
TABLE 26 eCLINICAL SOLUTIONS MARKET SIZE FOR PHASE I CLINICAL TRIALS, BY REGION, 2013-2020 (USD MILLION) 73
TABLE 27 NORTH AMERICA: eCLINICAL SOLUTIONS MARKET SIZE FOR PHASE I CLINICAL TRIALS, BY COUNTRY, 2013-2020 (USD MILLION) 73
TABLE 28 eCLINICAL SOLUTIONS MARKET SIZE FOR PHASE II CLINICAL TRIALS, BY REGION, 2013-2020 (USD MILLION) 75
TABLE 29 NORTH AMERICA: eCLINICAL SOLUTIONS MARKET SIZE FOR PHASE II CLINICAL TRIALS, BY COUNTRY, 2013-2020 (USD MILLION) 75
TABLE 30 eCLINICAL SOLUTIONS MARKET SIZE FOR PHASE III CLINICAL TRIALS, BY REGION, 2013-2020 (USD MILLION) 77
TABLE 31 NORTH AMERICA: eCLINICAL SOLUTIONS MARKET SIZE FOR PHASE III CLINICAL TRIALS, BY COUNTRY, 2013-2020 (USD MILLION) 77
TABLE 32 eCLINICAL SOLUTIONS MARKET SIZE FOR PHASE IV CLINICAL TRIALS, BY REGION, 2013-2020 (USD MILLION) 78
TABLE 33 NORTH AMERICA: eCLINICAL SOLUTIONS MARKET SIZE FOR PHASE IV CLINICAL TRIALS, BY COUNTRY, 2013-2020 (USD MILLION) 79
TABLE 34 GLOBAL eCLINICAL SOLUTIONS MARKET SIZE, BY END USER,
2013-2020 (USD MILLION) 81
TABLE 35 eCLINICAL SOLUTIONS MARKET SIZE FOR PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES, BY REGION, 2013-2020 (USD MILLION) 83
TABLE 36 EXAMPLES OF STRATEGIC ALLIANCES BETWEEN CROS AND PHARMA COMPANIES 84
TABLE 37 eCLINICAL SOLUTIONS MARKET SIZE FOR CONTRACT RESEARCH ORGANIZATIONS (CROS), BY REGION, 2013-2020 (USD MILLION) 85
TABLE 38 eCLINICAL SOLUTIONS MARKET SIZE FOR CONSULTING SERVICE COMPANIES,
BY REGION, 2013-2020 (USD MILLION) 86
TABLE 39 eCLINICAL SOLUTIONS MARKET SIZE FOR MEDICAL DEVICE MANUFACTURERS,
BY REGION, 2013-2020 (USD MILLION) 87
TABLE 40 eCLINICAL SOLUTIONS MARKET SIZE FOR HOSPITALS, BY REGION,
2013-2020 (USD MILLION) 88
TABLE 41 eCLINICAL SOLUTIONS MARKET SIZE FOR ACADEMIC RESEARCH INSTITUTES,
BY REGION, 2013-2020 (USD MILLION) 89
TABLE 42 eCLINICAL SOLUTIONS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION) 91
TABLE 43 NORTH AMERICA: eCLINICAL SOLUTIONS MARKET SIZE, BY COUNTRY,
2013-2020 (USD MILLION) 93
TABLE 44 NORTH AMERICA: eCLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT,
2013-2020 (USD MILLION) 93
TABLE 45 NORTH AMERICA: eCLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2013-2020 (USD MILLION) 94
TABLE 46 NORTH AMERICA: eCLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2013-2020 (USD MILLION) 94
TABLE 47 NORTH AMERICA: eCLINICAL SOLUTIONS MARKET SIZE, BY END USER,
2013-2020 (USD MILLION) 95
TABLE 48 U.S.: eCLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT,
2013-2020 (USD MILLION) 96
TABLE 49 U.S.: eCLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE,
2013-2020 (USD MILLION) 97
TABLE 50 CANADA: eCLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT,
2013-2020 (USD MILLION) 98
TABLE 51 CANADA: eCLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE,
2013-2020 (USD MILLION) 98
TABLE 52 EUROPEAN MEDICINES AGENCY (EMA)-APPROVED BIOSIMILARS 100
TABLE 53 EUROPE: eCLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT,
2013-2020 (USD MILLION) 103
TABLE 54 EUROPE: eCLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE,
2013-2020 (USD MILLION) 103
TABLE 55 EUROPE: eCLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE,
2013-2020 (USD MILLION) 104
TABLE 56 EUROPE: eCLINICAL SOLUTIONS MARKET SIZE, BY END USER,
2013-2020 (USD MILLION) 104
TABLE 57 ASIA-PACIFIC: eCLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT,
2013-2020 (USD MILLION) 107
TABLE 58 ASIA-PACIFIC: eCLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE,
2013-2020 (USD MILLION) 107
TABLE 59 ASIA-PACIFIC: eCLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2013-2020 (USD MILLION) 108
TABLE 60 ASIA-PACIFIC: eCLINICAL SOLUTIONS MARKET SIZE, BY END USER,
2013-2020 (USD MILLION) 108
TABLE 61 ROW: eCLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT,
2013-2020 (USD MILLION) 110
TABLE 62 ROW: eCLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE,
2013-2020 (USD MILLION) 110
TABLE 63 ROW: eCLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE,
2013-2020 (USD MILLION) 111
TABLE 64 ROW: eCLINICAL SOLUTIONS MARKET SIZE, BY END USER,
2013-2020 (USD MILLION) 111
TABLE 65 TOP 5 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS, 2013-2015 115
TABLE 66 TOP 5 NEW PRODUCT LAUNCHES AND PRODUCT ENHANCEMENTS, 2013-2015 116
TABLE 67 TOP 5 PRODUCT DEPLOYMENTS, 2013-2015 117
TABLE 68 TOP 5 MERGERS AND ACQUISITIONS, 2013-2015 118
TABLE 69 EXPANSIONS, 2013-2015 119
TABLE 70 TOP 5 OTHER DEVELOPMENTS, 2013-2015 120


LIST OF FIGURES

FIGURE 1 RESEARCH DESIGN 19
FIGURE 2 BREAKDOWN OF SUPPLY-SIDE PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 21
FIGURE 3 eCLINICAL SOLUTIONS MARKET: END-USER ANALYSIS APPROACH 24
FIGURE 4 eCLINICAL SOLUTIONS MARKET: BOTTOM-UP APPROACH 25
FIGURE 5 eCLINICAL SOLUTIONS MARKET: TOP-DOWN APPROACH 26
FIGURE 6 eCLINICAL SOLUTIONS MARKET: DATA TRIANGULATION 27
FIGURE 7 GLOBAL eCLINICAL SOLUTIONS MARKET, BY PRODUCT, 2015 (USD MILLION) 29
FIGURE 8 GLOBAL eCLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2015 VS. 2020 31
FIGURE 9 GLOBAL eCLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2015 VS. 2020 32
FIGURE 10 GLOBAL eCLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE,
2015 VS. 2020 (USD MILLION) 32
FIGURE 11 GLOBAL eCLINICAL SOLUTIONS MARKET, BY END USER,
2015 VS. 2020 (USD MILLION) 33
FIGURE 12 GLOBAL eCLINICAL SOLUTIONS MARKET, BY REGION, 2015 (USD MILLION) 34
FIGURE 13 EMERGING COUNTRIES OFFER HIGH GROWTH OPPORTUNITIES 35
FIGURE 14 EDC and CDMS SEGMENT WILL CONTINUE TO DOMINATE THE GLOBAL eCLINICAL SOLUTIONS MARKET IN 2020 36
FIGURE 15 WEB-HOSTED DELIVERY MODE SEGMENT DOMINATES THE GLOBAL eCLINICAL SOLUTIONS MARKET IN ALL REGIONAL SEGMENTS 37
FIGURE 16 PHASE III CLINICAL TRIALS SEGMENT WILL CONTINUE TO DOMINATE THE GLOBAL eCLINICAL SOLUTIONS MARKET IN 2020 38
FIGURE 17 ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATIONS MARKET IS EXPECTED TO WITNESS THE HIGHEST GROWTH RATE BETWEEN 2015 AND 2020 38
FIGURE 18 eCLINICAL SOLUTIONS MARKET SEGMENTATION 39
FIGURE 19 eCLINICAL SOLUTIONS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 40
FIGURE 20 THE EDC AND CDMS SEGMENT TO COMMAND THE LARGEST SHARE OF THE GLOBAL eCLINICAL SOLUTIONS MARKET IN 2015 47
FIGURE 21 NORTH AMERICA IS ESTIMATED TO BE THE LARGEST SEGMENT OF THE EDC AND CDMS MARKET IN 2015 49
FIGURE 22 ASIA-PACIFIC PROJECTED TO BE THE FASTEST-GROWING REGION IN THE CLINICAL TRIAL MANAGEMENT SYSTEMS (CTMS) MARKET DURING THE FORECAST PERIOD 52
FIGURE 23 NORTH AMERICA IS ESTIMATED TO BE THE LARGEST SEGMENT OF THE CLINICAL ANALYTICS PLATFORMS MARKET IN 2015 54
FIGURE 24 ASIA-PACIFIC PROJECTED TO BE THE FASTEST-GROWING REGION IN THE RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET 56
FIGURE 25 WEB-HOSTED (ON-DEMAND) SEGMENT TO DOMINATE THE GLOBAL eCLINICAL SOLUTIONS MARKET IN ALL REGIONS IN 2015 65
FIGURE 26 PHASE III TRIALS IS THE FASTEST-GROWING MARKET SEGMENT IN THE FORECAST PERIOD 71
FIGURE 27 NORTH AMERICA TO DOMINATE THE GLOBAL eCLINICAL SOLUTIONS MARKET FOR PHASE I CLINICAL TRIALS IN 2015 72
FIGURE 28 ASIA-PACIFIC PROJECTED TO BE THE FASTEST-GROWING REGION IN THE eCLINICAL SOLUTIONS MARKET FOR PHASE II TRIALS 74
FIGURE 29 NORTH AMERICA IS ESTIMATED TO BE THE LARGEST SEGMENT OF THE GLOBAL eCLINICAL SOLUTIONS MARKET FOR PHASE III TRIALS IN 2015 76
FIGURE 30 ASIA-PACIFIC OFFERS HIGH GROWTH OPPORTUNITIES FOR THE PLAYERS IN THE eCLINICAL SOLUTIONS MARKET FOR PHASE IV TRIALS 78
FIGURE 31 GLOBAL ECLINICAL SOLUTIONS MARKET SHARE, BY END USER, 2015 81
FIGURE 32 RandD EXPENDITURE OF THE TOP 10 PHARMACEUTICAL COMPANIES,
2013 VS. 2014 (USD MILLION) 82
FIGURE 33 NORTH AMERICA IS ESTIMATED TO BE THE LARGEST SEGMENT OF THE GLOBAL eCLINICAL SOLUTIONS MARKET FOR PHARMA AND BIOPHARMA COMPANIES
IN 2015 83
FIGURE 34 ASIA-PACIFIC PROJECTED TO BE THE FASTEST-GROWING REGION IN THE eCLINICAL SOLUTIONS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS 85
FIGURE 35 GLOBAL eCLINICAL SOLUTIONS MARKET: MARKET SIZE and GROWTH FORECAST,
BY REGION (2015-2020) 91
FIGURE 36 NORTH AMERICA: ECLINICAL SOLUTIONS MARKET SNAPSHOT 92
FIGURE 37 EUROPE: eCLINICAL SOLUTIONS MARKET SNAPSHOT 99
FIGURE 38 EUROPE: NUMBER OF BIOSIMILAR APPROVALS, 2006-2014 101
FIGURE 39 EUROPE: PHARMACEUTICAL RandD EXPENDITURE, BY COUNTRY (2012) 102
FIGURE 40 ASIA-PACIFIC: eCLINICAL SOLUTIONS MARKET SNAPSHOT 105
FIGURE 41 GLOBAL eCLINICAL SOLUTIONS MARKET SHARE, BY KEY PLAYER, 2014 112
FIGURE 42 BATTLE FOR MARKET SHARE: PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS, THE KEY GROWTH STRATEGY FOR MARKET PLAYERS 114
FIGURE 43 GEOGRAPHIC REVENUE MIX OF THE LEADING MARKET PLAYERS 121
FIGURE 44 ORACLE CORPORATION: COMPANY SNAPSHOT 122
FIGURE 45 MEDIDATA SOLUTIONS, INC.: COMPANY SNAPSHOT 128
FIGURE 46 PAREXEL INTERNATIONAL CORPORATION: COMPANY SNAPSHOT 132
FIGURE 47 DATATRAK INTERNATIONAL, INC.: COMPANY SNAPSHOT 139
FIGURE 48 MERGE HEALTHCARE INCORPORATED: COMPANY SNAPSHOT 148
FIGURE 49 OMNICOMM SYSTEMS, INC.: COMPANY SNAPSHOT 150

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.